HKD 1.01
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 0.12 HKD | -7.69% |
2022 | 0.13 HKD | 40.24% |
2021 | 0.09 HKD | 2.21% |
2020 | 0.09 HKD | -17.55% |
2019 | 0.11 HKD | -15.38% |
2018 | 0.13 HKD | 18.18% |
2017 | 0.11 HKD | 0.0% |
2016 | 0.11 HKD | 0.0% |
2015 | 0.11 HKD | 41.21% |
2014 | 0.08 HKD | -40.08% |
2013 | 0.13 HKD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2023 FY | - HKD | -7.69% |
2023 Q4 | 0.06 HKD | 0.0% |
2023 Q2 | 0.07 HKD | 0.0% |
2022 Q4 | 0.06 HKD | 0.0% |
2022 FY | - HKD | 40.24% |
2022 Q2 | 0.07 HKD | 0.0% |
2021 FY | - HKD | 2.21% |
2021 Q2 | 0.04 HKD | 0.0% |
2021 Q4 | 0.05 HKD | 0.0% |
2020 Q2 | 0.05 HKD | 0.0% |
2020 FY | - HKD | -17.55% |
2020 Q4 | 0.04 HKD | 0.0% |
2019 Q2 | 0.06 HKD | 0.0% |
2019 Q4 | 0.05 HKD | 0.0% |
2019 FY | - HKD | -15.38% |
2018 FY | - HKD | 18.18% |
2018 Q2 | 0.05 HKD | 0.0% |
2017 Q2 | 0.04 HKD | 0.0% |
2017 Q4 | 0.07 HKD | 0.0% |
2017 FY | - HKD | 0.0% |
2016 Q2 | 0.04 HKD | 0.0% |
2016 FY | - HKD | 0.0% |
2016 Q4 | 0.07 HKD | 0.0% |
2015 Q2 | 0.05 HKD | 0.0% |
2015 FY | - HKD | 41.21% |
2015 Q4 | 0.06 HKD | 0.0% |
2014 Q1 | 0.02 HKD | 0.0% |
2014 Q2 | 0.02 HKD | 0.0% |
2014 FY | - HKD | -40.08% |
2014 Q3 | 0.01 HKD | -40.65% |
2014 Q4 | 0.01 HKD | 0.0% |
2013 Q4 | 0.02 HKD | 0.0% |
2013 FY | - HKD | 0.0% |
2013 Q3 | 0.02 HKD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Pak Fah Yeow International Limited | 0.34 HKD | 64.706% |
Grand Pharmaceutical Group Limited | 0.54 HKD | 77.778% |
Extrawell Pharmaceutical Holdings Limited | -0.07 HKD | 275.953% |
Wai Yuen Tong Medicine Holdings Limited | -0.01 HKD | 1023.077% |
Qianhai Health Holdings Limited | -0.03 HKD | 485.852% |
Lee's Pharmaceutical Holdings Limited | 0.03 HKD | -322.535% |
Essex Bio-Technology Limited | 0.49 HKD | 75.51% |
Tongfang Kontafarma Holdings Limited | -0.01 HKD | 2407.692% |
PuraPharm Corporation Limited | -0.27 HKD | 144.444% |
SSY Group Limited | 0.44 HKD | 72.727% |
JBM (Healthcare) Limited | 0.15 HKD | 20.0% |
China Resources Pharmaceutical Group Limited | 0.68 HKD | 82.353% |